Joining a small biotech? Warning!

06.17.11-4-Most-Common-Career-Mistakes-FeaturedJim was excited to join a small biotech company.  He really enjoyed working in pharma, but his growth and progress had been limited at his current employer so when he offered a new job as a Director for a biotech company he packed up his family and moved cross country.   Continue reading »

Size matters:Online ads

screenshot_103POST SUMMARY: A small number of publishers are serving most of the non-viewable impressions. 56.1% of all impressions measured are not seen, but the average publisher viewability is 50.2%. Continue reading »

The demise of biotech

AccCIO-Yikes-300x203POST SUMMARY:  Over the holiday week I had the chance to catch up with some business colleagues over a beer and great Boston seafood appetizers.  If you want an example how big pharma mentality can kill innovative biotech companies, look no further than the examples of Biogen and Amgen. Continue reading »

News for pharma marketers

fridaynewsPOST SUMMARY: Welcome back.  Here are some stories that you may have missed from last week that are relevant to our business.  It seems the environment in which we market continues to change. Continue reading »

Physicians and social media

docssocmed64% of physicians use at least one of the types of social network while 36% do not use any, according to the Sources & Interactions Study, September 2013. This breaks down to 13% of doctors using all three types, 25% using 2 of the 3, and 26% using only 1 of the 3 types.

screenshot_94

 

Continue reading »

Medical Device tax impact: negligible

screenshot_93The 2.3% medical device tax imposed by the Affordable Care Act in 2010 was one of a number of additional revenue-raising provisions to finance health reform. This tax, which took effect on January 2013, is projected to collect approximately $38 billion of excise tax revenues over the next 10 years, resulting in $29 billion of net revenues, after accounting for offsets from other taxes.

Continue reading »

We have to be the change we need…

I don’t think I have seen any industry that is in more dire need of change than pharma.  Report after report continues to point out how pharma is lagging in one area or another and yet year after year, conference after conference, pharma remains stuck in the past as DTC marketing spirals towards irrelevance.

time-for-change

Continue reading »

Pharma lagging in digital…

imagesPOST SUMMARY:  According to McKinsey&Company “unlike successful B2C companies in other industries— which offer mobile solutions, provide personalized product recommendations, and empower customer-service agents with a 360-degree view of the customer—most healthcare providers and payors are lagging, as are pharmaceutical companies and medical-device manufacturers.”  How much monger does pharma need to get the wake-up call? Continue reading »